Chicago Pacific Founders (CPF) has announced an investment in Nexben.

Nexben, founded in 2015 and based in Grand Rapids, Michigan, is a fintech company that provides plan administration and payment solutions for the benefits industry.

CPF, founded in 2014 and based in Chicago and San Francisco, is a private equity firm focused on investing in growth companies within value-based care, healthcare services, AI and tech-enabled services, and caring for aging populations.  

Terms of the investment were not disclosed.

Home and alternate-site infusion therapy is a highly fragmented market. Just two large players command 35% to 40% market share while more than 800 smaller providers making up the remainder. And that fragmentation is exactly what’s drawing private equity interest.

Don Hooker, director of research at Bourne Partners, a leading life science investment firm, joins McGuireWoods partner and host Geoff Cockrell to unpack the investment landscape. Don explains that delivering drugs at home or in alternate sites can cost roughly half as much as treatment in an inpatient setting. He also outlines the two main pressures shaping the home infusion space.

Tune in for his insights about reimbursement dynamics, labor intensity, drug pricing and “back-end” strategic buyers such as Option Care Health.

Serent Capital has announced an investment in Saisystems Health.

Saisystems, founded in 1987 and based in Shelton, Connecticut, is a provider of revenue cycle management and electronic health record solutions for physicians serving skilled nursing facilities.

Serent, founded in 2008 and with offices in San Francisco and Austin, Texas, is a growth-focused private equity firm that invests in founder-led B2B software and technology-enabled services companies.

Terms of the investment were not disclosed.

This year’s Healthcare Private Equity and Finance Conference, hosted by McGuireWoods, will take place April 29-30, 2026, at The Ritz-Carlton Chicago.

The two-day event brings together investors, healthcare executives, lenders, and advisors to discuss healthcare M&A activity, regulatory trends, and emerging opportunities.

Learn more about the event and register for the conference.

NewSpring Healthcare has led a $140 million capital raise for Honest Health, according to a news release.

Honest Health, formed in 2021 and based in Nashville, partners with health systems to support value-based care models, particularly for Medicare patients.

NewSpring Healthcare is a sector-focused strategy of NewSpring Capital. NewSpring, founded in 1999 and based in Radnor, Pennsylvania, is a private investment firm that invests in the lower-middle market. The firm invests in several industries, including healthcare. NewSpring Healthcare targets healthcare companies across the healthcare services, specialty pharmaceutical and medical technology sectors.

The capital raise was supported by K2 HealthVentures and Honest Health’s existing investors and institutional partners.

In this webinar turned episode of the Becker Private Equity & Business Podcast, Scott Becker sits down with David Pivnick, partner at McGuireWoods, to discuss the habits, perspective, and discipline that often underpin long-term professional success.

Their conversation touches on setting meaningful goals, showing up consistently, focusing on individual strengths, maintaining balance with family, and approaching career development with a long-term mindset.

Seven Hills Capital has announced the closing of its second fund.

The fund, Seven Hills Capital Fund II, closed at its $235 million hard cap. McGuireWoods LLP provided legal counsel in connection with the fundraising.

Seven Hills, founded in 2016 and based in Chicago, seeks control equity investments exclusively in healthcare. The firm targets companies in the provider services and non-reimbursement sectors with $2 million to $50 million in revenue and $1 million to $20 million in EBITDA. Seven Hills is flexible in its investment sizes.

Ascend Capital Partners announced the closing of its second fund.

The fund, Ascend Capital Partners Fund II, closed with $791 million in total commitments, exceeding its initial $700 million target.

Ascend Fund II will invest across physician and provider services, value-based care enablement companies and healthcare IT.

Ascend, founded in 2019 and based in New York, is a growth-oriented, healthcare-focused private equity firm.

In a recent episode of the Becker Private Equity & Business Podcast, Amber Walsh, partner at McGuireWoods, discusses current trends in healthcare private equity and outlines how this year’s Healthcare Private Equity Conference (April 29–30, 2026) is structured. The event will focus on four core areas: life sciences, traditional provider services, innovation, and operational excellence, reflecting the diverse opportunities and challenges facing investors and operators in today’s healthcare market.

Kinderhook Industries will acquire Enhabit in a deal value at approximately $1.1 billion, according to a news release.

Enhabit (NYSE: EHAB), founded in 2022 when it was spun off from Encompass Health Corp. and based in Dallas, is a national home health and hospice provider.

Kinderhook, founded in 2003 and based in New York, is a middle market private equity firm. The firm specializes in management buyouts of entrepreneurial-owned businesses operating in healthcare services and a few other sectors.

Upon completion of the transaction, Enhabit’s common stock will cease trading on the New York Stock Exchange, and the company will become a privately held entity.